FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036156178> ?p ?o ?g. }

• W3036156178 endingPage "1447" @default.
• W3036156178 startingPage "1434" @default.
• W3036156178 abstract "Abstract Background Management of diabetes mellitus induced-erectile dysfunction (DMED) is challenging because of its poor responses to phosphodiesterase type 5 inhibitors. Increasingly important roles of 12-lipoxygenase (12-LOX) have been proven in diabetes mellitus. Aim To investigate 12-LOX activity and therapeutic effect of its inhibitor, baicalein (BE), on DMED. Methods Intraperitoneal streptozotocin injection was used to induce type I DM, and an apomorphine test was used to evaluate erectile function. In experiment A, we assessed 12-LOX expression alteration in the corpus cavernosum (CC) of rats with DMED of different levels of severity. In experiment B, rats with DMED were intraperitoneally injected with BE for 4 weeks, and control rats were injected with vehicles. The erectile function was tested by cavernous nerve stimulation before penile tissue was harvested. We performed Western blot, immunohistochemistry, immunofluorescence, Masson trichrome staining, and enzyme-linked immunosorbent assays to measure related proteins in CC. Main Outcome Measure The main outcome measures included rectile response, histologic examination, and expression alteration of related proteins. Results 12-LOX upregulation was associated with the progression of type I DMED. After 4 weeks treatment, compared with the DMED group, the DMED + BE group showed better erectile responses to cavernous nerve stimulation. In the DMED + BE group, significantly enhanced endothelial nitric oxide synthase/nitric oxide/cyclic guanosine monophosphate pathway, reduced 12-LOX expression, and inhibited p38 mitogen-activated protein kinase/arginase II/L-arginine pathway were showed in CC relative to the DMED group. In addition, overactivated oxidative stress and fibrosis in the DMED group were both partially ameliorated in the DMED + BE group. Clinical Implications BE may be considered as an effective therapy for DMED, but needs to be verified in future human investigations. Strengths & Limitations The role of 12-LOX and its inhibitor, BE, is firstly demonstrated in rats with type I DMED. However, the experimental data are derived from animal models with without evidences from cellular-based experiments. Conclusion 12-LOX might serve as an important factor in the pathogenesis of type I DMED. BE alleviated erectile dysfunction in rats with type I DMED probably by inhibiting 12-LOX expression, ameliorating endothelial nitric oxide synthase dysfunction, as well as suppressing oxidative stress and fibrosis." @default.
• W3036156178 created "2020-06-25" @default.
• W3036156178 creator A5001003076 @default.
• W3036156178 creator A5011978867 @default.
• W3036156178 creator A5016968354 @default.
• W3036156178 creator A5020497561 @default.
• W3036156178 creator A5023347212 @default.
• W3036156178 creator A5034498602 @default.
• W3036156178 creator A5036320682 @default.
• W3036156178 creator A5045570568 @default.
• W3036156178 creator A5065238326 @default.
• W3036156178 creator A5082402921 @default.
• W3036156178 creator A5085142676 @default.
• W3036156178 date "2020-06-22" @default.
• W3036156178 modified "2023-10-10" @default.
• W3036156178 title "Baicalein Alleviates Erectile Dysfunction Associated with Streptozotocin-Induced Type I Diabetes by Ameliorating Endothelial Nitric Oxide Synthase Dysfunction, Inhibiting Oxidative Stress and Fibrosis" @default.
• W3036156178 cites W1981551267 @default.
• W3036156178 cites W2003588603 @default.
• W3036156178 cites W2010914260 @default.
• W3036156178 cites W2013903004 @default.
• W3036156178 cites W2058645346 @default.
• W3036156178 cites W2062907730 @default.
• W3036156178 cites W2115373423 @default.
• W3036156178 cites W2116513332 @default.
• W3036156178 cites W2119996295 @default.
• W3036156178 cites W2121968925 @default.
• W3036156178 cites W2122948438 @default.
• W3036156178 cites W2144873895 @default.
• W3036156178 cites W2164832056 @default.
• W3036156178 cites W2165473528 @default.
• W3036156178 cites W2275190058 @default.
• W3036156178 cites W2277244867 @default.
• W3036156178 cites W2346528753 @default.
• W3036156178 cites W2468141605 @default.
• W3036156178 cites W2507330310 @default.
• W3036156178 cites W2518069843 @default.
• W3036156178 cites W2521544285 @default.
• W3036156178 cites W2522083558 @default.
• W3036156178 cites W2573217897 @default.
• W3036156178 cites W2599008286 @default.
• W3036156178 cites W2613225531 @default.
• W3036156178 cites W2767838243 @default.
• W3036156178 cites W2810676635 @default.
• W3036156178 cites W2891632658 @default.
• W3036156178 cites W2895786968 @default.
• W3036156178 cites W2945323630 @default.
• W3036156178 cites W2954531847 @default.
• W3036156178 cites W2954844010 @default.
• W3036156178 cites W2961718485 @default.
• W3036156178 cites W2965627983 @default.
• W3036156178 cites W2970742453 @default.
• W3036156178 cites W335586109 @default.
• W3036156178 doi "https://doi.org/10.1016/j.jsxm.2020.04.390" @default.
• W3036156178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32586748" @default.
• W3036156178 hasPublicationYear "2020" @default.
• W3036156178 type Work @default.
• W3036156178 sameAs 3036156178 @default.
• W3036156178 citedByCount "15" @default.
• W3036156178 countsByYear W30361561782021 @default.
• W3036156178 countsByYear W30361561782022 @default.
• W3036156178 countsByYear W30361561782023 @default.
• W3036156178 crossrefType "journal-article" @default.
• W3036156178 hasAuthorship W3036156178A5001003076 @default.
• W3036156178 hasAuthorship W3036156178A5011978867 @default.
• W3036156178 hasAuthorship W3036156178A5016968354 @default.
• W3036156178 hasAuthorship W3036156178A5020497561 @default.
• W3036156178 hasAuthorship W3036156178A5023347212 @default.
• W3036156178 hasAuthorship W3036156178A5034498602 @default.
• W3036156178 hasAuthorship W3036156178A5036320682 @default.
• W3036156178 hasAuthorship W3036156178A5045570568 @default.
• W3036156178 hasAuthorship W3036156178A5065238326 @default.
• W3036156178 hasAuthorship W3036156178A5082402921 @default.
• W3036156178 hasAuthorship W3036156178A5085142676 @default.
• W3036156178 hasConcept C126322002 @default.
• W3036156178 hasConcept C134018914 @default.
• W3036156178 hasConcept C137183658 @default.
• W3036156178 hasConcept C2776151105 @default.
• W3036156178 hasConcept C2777525119 @default.
• W3036156178 hasConcept C2777622882 @default.
• W3036156178 hasConcept C2779280383 @default.
• W3036156178 hasConcept C2779929075 @default.
• W3036156178 hasConcept C2780559512 @default.
• W3036156178 hasConcept C2780994212 @default.
• W3036156178 hasConcept C513476851 @default.
• W3036156178 hasConcept C519581460 @default.
• W3036156178 hasConcept C555293320 @default.
• W3036156178 hasConcept C71924100 @default.
• W3036156178 hasConcept C98274493 @default.
• W3036156178 hasConceptScore W3036156178C126322002 @default.
• W3036156178 hasConceptScore W3036156178C134018914 @default.
• W3036156178 hasConceptScore W3036156178C137183658 @default.
• W3036156178 hasConceptScore W3036156178C2776151105 @default.
• W3036156178 hasConceptScore W3036156178C2777525119 @default.
• W3036156178 hasConceptScore W3036156178C2777622882 @default.
• W3036156178 hasConceptScore W3036156178C2779280383 @default.
• W3036156178 hasConceptScore W3036156178C2779929075 @default.
• W3036156178 hasConceptScore W3036156178C2780559512 @default.
• W3036156178 hasConceptScore W3036156178C2780994212 @default.

• next